The Glycated Haemoglobin Testing market involves products that are used to measure the percentage of hemoglobin molecules in the blood that are coated with sugar. Glycated hemoglobin testing provides doctors with an indication of a patient's average blood glucose levels over the previous two to three months and is crucial for managing diabetes.

The glycated haemoglobin testing market is estimated to be valued at USD 239 Mn in 2024 and is expected to reach USD 426 Mn by 2031, growing at a compound annual growth rate (CAGR) of 8.6% from 2024 to 2031.

Key players operating in the Glycated Haemoglobin Testing market are Abbott Laboratories, Bio-Rad Laboratories, Danaher Corporation (Beckman Coulter), F. Hoffmann-La Roche Ltd., and EKF Diagnostics Holdings plc.



The Glycated Haemoglobin Testing Market offers significant growth opportunities owing to the increasing geriatric population globally that is more susceptible to diabetes. Furthermore, the availability of point-of-care testing and home-based testing is also expected to drive the demand.



The market is witnessing high expansion in regions such as Asia Pacific and Latin America due to the rising awareness about diabetes management and increasing healthcare expenditure in emerging economies such as China, India, Brazil, and Mexico.



Market Drivers

The global Glycated Haemoglobin Testing market is primarily driven by the rising prevalence of diabetes worldwide. According to recent data by the International Diabetes Federation, around 537 million adults between the ages of 20-79 years were living with diabetes in 2021 across the globe and the number is projected to rise to 643 million by 2030 and 783 million by 2045. Glycated hemoglobin testing plays a crucial role in the management of diabetes and its complications, thereby significantly contributing to the growth of this market.

PEST Analysis

Political: Regulations regarding diabetes screening and management are expected to drive the growth of the glycated haemoglobin testing market. Governments are promoting awareness campaigns about diabetes control and treatment.



Economic: Rise in disposable incomes is increasing demand for advanced healthcare facilities for effective diabetes management. Growing diabetic patient pool is prompting hospitals and diagnostic centers to invest in glycated haemoglobin testing products.



Social: Changing lifestyles and increasing prevalence of obesity and diabetes are key factors influencing greater adoption of glycated haemoglobin testing. Growing health consciousness in society is raising awareness about benefits of regular blood glucose monitoring.



Technological: Introduction of user-friendly and portable blood glucose monitoring devices are supporting in-home usage. Advanced technologies like AI are helping in automated analysis of glycated haemoglobin levels from blood samples.



Regions with high market concentration

North America dominates the glycated haemoglobin testing market in terms of value owing to increasing burden of diabetes, favorable reimbursement policies, and widespread adoption of home-based testing. Asia Pacific is also emerging as a major market led by large diabetic populations in countries like India and China. Growing healthcare expenditure of governments and patients is boosting regional market growth.



Fastest growing region

Asia Pacific region is poised to witness the fastest growth during the forecast period due to rising awareness, improving access to diagnosis and treatment, and increasing healthcare spending. Favorable government policies for diabetes management in countries like India and China are additionally supporting the growth of glycated haemoglobin testing market in Asia Pacific.

Get this Report in Japanese Language: 糖化ヘモグロビン検査市場

Get this Report in Korean Language: 당화 헤모글로빈 검사 시장

About Author:

Ravina Pandya, Content Writer, has a strong foothold in the market research industry. She specializes in writing well-researched articles from different industries, including food and beverages, information and technology, healthcare, chemical and materials, etc. (https://www.linkedin.com/in/ravina-pandya-1a3984191)